Nkarta (NKTX) Interest Expenses (2019 - 2026)
Nkarta (NKTX) posted quarterly Interest Expenses of $6.0 million for Q1 2026, up 8.09% year-over-year from $5.6 million in Q1 2025, and down 1.43% quarter-over-quarter from $6.1 million in Q4 2025.
Nkarta (NKTX) Interest Expenses (2019 - 2026) Analysis & Trends
Nkarta's Interest Expenses history runs 8 years deep, the most recent figure standing at $6.0 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 8.09% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $22.4 million (down 30.62% YoY), while the FY2025 annual figure was $151.4 million, up 643.87% from the prior year.
- Interest Expenses for Q1 2026 stood at $6.0 million, down from $6.1 million in the prior quarter.
- The five-year high for Interest Expenses was $146.9 million in Q2 2023, with the low at $600000.0 in Q1 2022.
- The 5-year median for Interest Expenses is $6.2 million (2024), against an average of $37.5 million.
- The sharpest annual moves came in 2022 and 2024: Interest Expenses surged 5343.27% in 2022, then slumped 96.08% in 2024.
- Nkarta's Interest Expenses stood at $4.0 million in 2022, then soared by 294.88% to $15.7 million in 2023, then slumped by 69.69% to $4.8 million in 2024, then gained by 27.54% to $6.1 million in 2025, then fell by 1.43% to $6.0 million in 2026.
- Business Quant data shows NKTX's Interest Expenses at $6.0 million in Q1 2026, $6.1 million in Q4 2025, and $37.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Nkarta | 201.14 Mn | 201.14 Mn | - | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 105.36 Mn |
| Jun 30, 2026 | 105.36 Mn |
| Mar 31, 2026 | 6.00 Mn |
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 6.09 Mn |
| Dec 31, 2025 | 6.09 Mn |
| Sep 30, 2025 | 37.08 Mn |
| Sep 30, 2025 | 37.08 Mn |
| Jun 30, 2025 | 38.93 Mn |
| Jun 30, 2025 | 38.93 Mn |
| Mar 31, 2025 | 5.55 Mn |
| Mar 31, 2025 | 5.55 Mn |
| Dec 31, 2024 | 4.77 Mn |
| Dec 31, 2024 | 4.77 Mn |
| Sep 30, 2024 | 6.23 Mn |
| Sep 30, 2024 | 6.23 Mn |
| Jun 30, 2024 | 5.76 Mn |
| Jun 30, 2024 | 5.76 Mn |
| Mar 31, 2024 | 30.91 Mn |
| Mar 31, 2024 | 30.91 Mn |